Scheme 1:
Summary of tumor hypoxia directed nanotherapy in combination with Sorafenib for achieving multiple benefits against cancer, such as reversing drug resistance, inducing apoptosis and reprogramming macrophages.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.